Compare ESTA & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESTA | ATRC |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | 2018 | 2005 |
| Metric | ESTA | ATRC |
|---|---|---|
| Price | $87.84 | $34.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $86.86 | $51.17 |
| AVG Volume (30 Days) | 767.0K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 42.67 | ★ 74.74 |
| EPS | N/A | ★ N/A |
| Revenue | $61,208,000.00 | ★ $201,630,000.00 |
| Revenue This Year | $28.05 | $15.27 |
| Revenue Next Year | $26.21 | $12.21 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | 15.40 |
| 52 Week Low | $33.35 | $25.36 |
| 52 Week High | $92.84 | $43.18 |
| Indicator | ESTA | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 59.49 | 70.23 |
| Support Level | $63.71 | $34.16 |
| Resistance Level | N/A | $34.38 |
| Average True Range (ATR) | 3.84 | 1.50 |
| MACD | -0.46 | 0.62 |
| Stochastic Oscillator | 62.64 | 91.94 |
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.